Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CALA

Calithera Biosciences

$11.60

0.65 (5.94%)

, INCY

Incyte

$124.54

-1.36 (-1.08%)

10:39
04/20/17
04/20
10:39
04/20/17
10:39
Hot Stocks
Calithera says CB-1151 Phase 1 data accepted for ASCO oral presentation »

Calithera Biosciences…

CALA

Calithera Biosciences

$11.60

0.65 (5.94%)

INCY

Incyte

$124.54

-1.36 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

CALA

Calithera Biosciences

$11.55

-0.05 (-0.43%)

07:55
04/03/17
04/03
07:55
04/03/17
07:55
Initiation
Calithera Biosciences initiated at Leerink »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

Over a month ago
CALA

Calithera Biosciences

$10.65

0.25 (2.40%)

07:18
03/28/17
03/28
07:18
03/28/17
07:18
Hot Stocks
Calithera Biosciences receives $12M milestone payment from Incyte »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALA

Calithera Biosciences

$10.55

-1.8 (-14.57%)

06:37
03/22/17
03/22
06:37
03/22/17
06:37
Syndicate
Calithera Biosciences 6.83M share Secondary priced at $10.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

ESPR

Esperion

$41.22

17.55 (74.14%)

, CALA

Calithera Biosciences

$12.35

-0.05 (-0.40%)

17:33
03/20/17
03/20
17:33
03/20/17
17:33
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Esperion (ESPR),…

ESPR

Esperion

$41.22

17.55 (74.14%)

CALA

Calithera Biosciences

$12.35

-0.05 (-0.40%)

OCUL

Ocular Therapeutix

$9.87

0.37 (3.89%)

LJPC

La Jolla

$38.44

2.56 (7.13%)

MMSI

Merit Medical

$31.55

0.2 (0.64%)

GBDC

Golub Capital

$19.42

0.02 (0.10%)

GEL

Genesis Energy

$31.60

-0.88 (-2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 28

    Mar

  • 19

    Jul

  • 21

    Mar

  • 23

    Mar

CALA

Calithera Biosciences

$12.35

-0.05 (-0.40%)

16:03
03/20/17
03/20
16:03
03/20/17
16:03
Syndicate
Calithera Biosciences files to sell 4.5M in common stock »

Leerink Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALA

Calithera Biosciences

$13.70

-0.5 (-3.52%)

16:20
03/16/17
03/16
16:20
03/16/17
16:20
Hot Stocks
Calithera Biosciences sees cash, cash equivalents $95M-$105M at 2017-end »

Calithera expects that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

CALA

Calithera Biosciences

$13.70

-0.5 (-3.52%)

, INCY

Incyte

$148.44

-4.22 (-2.76%)

16:18
03/16/17
03/16
16:18
03/16/17
16:18
Earnings
Calithera Biosciences reports Q4 EPS (45c), consensus (48c) »

Calithera (CALA) reported…

CALA

Calithera Biosciences

$13.70

-0.5 (-3.52%)

INCY

Incyte

$148.44

-4.22 (-2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

  • 01

    Apr

  • 02

    Apr

  • 19

    Apr

CALA

Calithera Biosciences

$12.05

-0.05 (-0.41%)

14:58
03/10/17
03/10
14:58
03/10/17
14:58
Hot Stocks
Breaking Hot Stocks news story on Calithera Biosciences »

Wellington Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

CALA

Calithera Biosciences

$12.40

0.4 (3.33%)

12:17
03/06/17
03/06
12:17
03/06/17
12:17
Hot Stocks
Breaking Hot Stocks news story on Calithera Biosciences »

Hawkes Bay Master…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.